SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-17-028405
Filing Date
2017-07-21
Accepted
2017-07-21 17:41:35
Documents
1
Period of Report
2017-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1642
  Complete submission text file 0001140361-17-028405.txt   2991
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
SARAN ATUL (Reporting) CIK: 0001591070 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 17977290